GR3017201T3 - Procedure for preparing human factor VIII and analogs thereof. - Google Patents

Procedure for preparing human factor VIII and analogs thereof.

Info

Publication number
GR3017201T3
GR3017201T3 GR950402314T GR950402314T GR3017201T3 GR 3017201 T3 GR3017201 T3 GR 3017201T3 GR 950402314 T GR950402314 T GR 950402314T GR 950402314 T GR950402314 T GR 950402314T GR 3017201 T3 GR3017201 T3 GR 3017201T3
Authority
GR
Greece
Prior art keywords
factor viii
procedure
analogue
analogs
human factor
Prior art date
Application number
GR950402314T
Other languages
English (en)
Inventor
Gerard Mignot
Nicolas Bihoreau
Philippe Adamowicz
Original Assignee
Tm Innovation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tm Innovation filed Critical Tm Innovation
Publication of GR3017201T3 publication Critical patent/GR3017201T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GR950402314T 1990-02-05 1995-08-23 Procedure for preparing human factor VIII and analogs thereof. GR3017201T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR909001302A FR2657884B1 (fr) 1990-02-05 1990-02-05 Procede pour la preparation du facteur viii humain et d'analogues du facteur viii.

Publications (1)

Publication Number Publication Date
GR3017201T3 true GR3017201T3 (en) 1995-11-30

Family

ID=9393391

Family Applications (1)

Application Number Title Priority Date Filing Date
GR950402314T GR3017201T3 (en) 1990-02-05 1995-08-23 Procedure for preparing human factor VIII and analogs thereof.

Country Status (10)

Country Link
US (2) US5422250A (el)
EP (1) EP0441695B1 (el)
JP (1) JPH06113879A (el)
AT (1) ATE123069T1 (el)
CA (1) CA2035691A1 (el)
DE (1) DE69109886T2 (el)
DK (1) DK0441695T3 (el)
ES (1) ES2075378T3 (el)
FR (1) FR2657884B1 (el)
GR (1) GR3017201T3 (el)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2657884B1 (fr) * 1990-02-05 1994-09-02 Tm Innovation Procede pour la preparation du facteur viii humain et d'analogues du facteur viii.
US5318898A (en) * 1991-04-02 1994-06-07 Genetics Institute, Inc. Production of recombinant bone-inducing proteins
DK53792D0 (da) * 1992-04-24 1992-04-24 Novo Nordisk As Fremgangsmaade til fremstilling af proteiner
EP0679192A1 (en) * 1992-11-17 1995-11-02 Novo Nordisk A/S Improved recombinant production of proteins having factor viii:c activity
JP3428687B2 (ja) * 1993-06-30 2003-07-22 財団法人化学及血清療法研究所 組織因子凝固系インヒビターの調製法
SE9303601D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Improved cell cultivation method and medium
EP1482031B1 (en) 1996-08-30 2015-10-28 Life Technologies Corporation Serum-free mammalian cell culture medium, and uses thereof
JP2002526455A (ja) 1998-09-21 2002-08-20 ジェネティックス インスティテュート インク． 治療用たんぱく質に対する免疫応答を下方変調する方法
EP2042196B1 (en) 2001-10-10 2016-07-13 ratiopharm GmbH Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF)
US20030181416A1 (en) * 2002-01-10 2003-09-25 Comper Wayne D. Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
WO2006113861A2 (en) * 2005-04-20 2006-10-26 Wyeth Mammalian expression systems
US20070087061A1 (en) * 2005-10-14 2007-04-19 Medafor, Incorporated Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion, or as a matrix for delivery of therapeutic components
US20070086958A1 (en) * 2005-10-14 2007-04-19 Medafor, Incorporated Formation of medically useful gels comprising microporous particles and methods of use
LT2126106T (lt) 2007-02-23 2018-01-10 Sk Chemicals Co., Ltd. Viii faktoriaus ir jo darinių gavimo ir gryninimo būdas
KR101808751B1 (ko) 2009-11-13 2017-12-13 그리폴스 테라퓨틱스 인코포레이티드 폰 빌레브란트 인자(ｖＷＦ)-함유 제제, 및 그와 관련된 방법, 키트 및 용도
AU2012324020A1 (en) 2011-12-30 2013-07-18 Grifols, S.A. Method for purifying Factor VIII
JP2014138614A (ja) * 2014-04-09 2014-07-31 Sk Chemicals Co Ltd 第ｖｉｉｉ因子とその誘導体の製造及び精製方法
US10119117B2 (en) 2016-01-28 2018-11-06 Nanogen Pharmaceutical Biotechnology Co., Ltd Universal, glycosylation enhancer, completely chemically defined medium formulation
JP6351679B2 (ja) * 2016-09-30 2018-07-04 エスケー ケミカルズ カンパニー リミテッド 第ｖｉｉｉ因子とその誘導体の製造及び精製方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803115A (en) * 1972-05-17 1974-04-09 Baxter Laboratories Inc Stabilization of ahf using heparin
US4443546A (en) * 1980-07-07 1984-04-17 The Beth Israel Hospital Association Process and composition for propagating mammalian cells
US4359463A (en) * 1980-11-26 1982-11-16 Rock Gail A Stabilization of Factor VIII activity in whole blood or blood plasma
US4397841A (en) * 1982-06-28 1983-08-09 Monsanto Company Production of blood coagulation factor VIII:C
NZ206699A (en) * 1982-12-30 1989-08-29 Bio Response Inc Process for the production of serum independent cell lines
US5132223A (en) * 1983-11-10 1992-07-21 Thomas Jefferson University Process and medium for cloning and long-term serial cultivation of adult human endothelial cells
ZA852099B (en) 1984-03-26 1985-12-24 Meloy Lab Recombinant factor viii-c.
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
US4670394A (en) * 1984-11-16 1987-06-02 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Isolation and culture of adrenal medullary endothelial cells producing blood clotting factor VIII:C
GB8505882D0 (en) * 1985-03-07 1985-04-11 Central Blood Lab Authority Purification of blood coagulation factor viii
DE3785102T2 (de) 1986-01-03 1993-07-22 Genetics Inst Verfahren zur herstellung von faktor-viii:c-typ-proteinen.
US5198349A (en) * 1986-01-03 1993-03-30 Genetics Institute, Inc. Method for producing factor VIII:C and analogs
FI98829C (fi) 1986-01-27 1997-08-25 Chiron Corp Menetelmä rekombinoidun proteiinikompleksin valmistamiseksi, jolla on humaanitekijä VIII:C-aktiivisuutta
DK155388C (da) 1986-07-08 1989-10-23 Palle Pedersen Laas
EP0254076B1 (en) * 1986-07-11 1991-05-08 Miles Inc. Improved recombinant protein production
NO872932L (no) 1986-07-18 1988-01-19 Gist Brocades Nv Fremgangsmaate for fremstilling av proteiner med faktorviiiaktivitet ved hjelp av mikrobielle vertsceller, eksprimeringsvektorer, vertsceller, antibiotika.
US4980456A (en) * 1987-04-06 1990-12-25 Scripps Clinic And Research Foundation Recombinant factor VIIIC derived fragments
EP0690126B1 (en) 1987-06-12 2001-11-28 Baxter Aktiengesellschaft Novel proteins with factor VIII activitiy: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them
IL86693A (en) * 1987-06-12 1994-06-24 Stichting Centraal Lab Proteins with factor VIII activity, process for their preparation using genetically engineered cells and pharmaceutical compositions containing them
FR2619314B1 (fr) 1987-08-11 1990-06-15 Transgene Sa Analogue du facteur viii, procede de preparation et composition pharmaceutique le contenant
JPH0387173A (ja) * 1987-09-10 1991-04-11 Teijin Ltd ヒト活性化天然型ファクター８ｃの製造方法及びそれに用いる形質転換体
FR2657884B1 (fr) * 1990-02-05 1994-09-02 Tm Innovation Procede pour la preparation du facteur viii humain et d'analogues du facteur viii.

Also Published As

Publication number Publication date
DE69109886D1 (de) 1995-06-29
JPH06113879A (ja) 1994-04-26
CA2035691A1 (fr) 1991-08-06
FR2657884A1 (fr) 1991-08-09
DK0441695T3 (da) 1995-10-16
EP0441695A1 (fr) 1991-08-14
ATE123069T1 (de) 1995-06-15
EP0441695B1 (fr) 1995-05-24
US5707832A (en) 1998-01-13
US5422250A (en) 1995-06-06
DE69109886T2 (de) 1996-02-29
FR2657884B1 (fr) 1994-09-02
ES2075378T3 (es) 1995-10-01

Similar Documents

Publication Publication Date Title
GR3017201T3 (en) Procedure for preparing human factor VIII and analogs thereof.
IL83567A (en) Starburst conjugates with a carried material,such as an agricultural or pharmaceutical material
DE69527626D1 (de) Methoden und mittel zur herstellung von hyaluronsäure
FR2628109B1 (fr) Amphireguline, glycoproteine bifonctionnelle regulatrice de la croissance et son procede de preparation
AU574288B2 (en) Chair
DE69021353D1 (de) Anordnung zur Regelung der Neigung eines Stuhls.
EP0251584A3 (en) A synchronization service for a distributed operating system or the like
IT8820988A0 (it) Procedimento per la produzione di nero fumo.
IL86895A (en) De-mannosyl teicoplanin derivativesuseful as antibioticsand animal growthsupplements, and theirpreparation
USD298809S (en) Artificial flower with inflated blossom
HU9904356D0 (en) Process for producing alfa,alfa-difuoro-beta-silyloxy-1,3-dioxolane-4-propanoic acid esters
USD275156S (en) Surgeon's chair with backrest
AU5445090A (en) Plant growing and cultivation system
HUT59136A (en) Process for producing 3-(pyroglutamyl)-l-thiazolidine-4-carboxylic acid and its derivatives
NO891984D0 (no) Fremgangsmaate for fremstilling av 1,4-dikydro-4-okso-kinolin-3-karboksylsyreestere.
HUT57010A (en) Process for using streptomyces ncimb 40227 strain as biostimulant in the agricultural production
EP0254239A3 (en) Optically pure 1,3-dioxenones, methods for preparing same and use thereof
DE69013425D1 (de) Pseudomonasmutant, yzh-Stamm und Verfahren zur Herstellung der 851yzh-Nährlösung mittels dieses Stammes.
GB8820357D0 (en) Solid alkene polymerization catalyst components & process for their preparation
DE3878988D1 (de) 1,2-di(4-isobutylphenyl)aethylen, dessen herstellung und verwendung als zwischenprodukt.
AU8342991A (en) Bipolar signal amplification or generation
ZA893917B (en) New avermectins with a cleaved furan ring and an 8a hydroxy group
ES455245A1 (es) Un procedimiento para la preparacion de nuevos 1,3-dihidro- 1'-dimetilfosfimilalcohil-3-fenislespino (isobenzofurano)s.
EP0342422A3 (en) Process for the preparation of 2',3'-dideoxynucleosides, and intermediates used therein
ITMI912060A1 (it) BIOMASSA BATTERICA DISIDRATATA PER USO AGRO-ALIMENTARE PRESENTANTE UNyELEVATA VITALITA' RESIDUA, METODO PER PREPARARE DETTA BIOMASSA ED APPARECCHIATURA PER ATTUARE TALE METODO.